CWM
ALAB icon

CIBC World Markets’s Astera Labs ALAB Stock Holding History

CIBC World Markets’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$21.4M Buy
+128,741
New +$21.5M 0.1% 139

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

CIBC World Markets's ALAB Position: Q4 2025 in Review

CIBC World Markets opened a new position in Astera Labs (ALAB) in Q4 2025: 128,741 shares worth $21.4M. The stake represents 0.1% of the portfolio and ranks #139 among its holdings.

701 funds tracked by Wall St. Rank hold ALAB as of Q4 2025.

  • CIBC World Markets held 128,741 shares of Astera Labs worth $21.4M as of Q4 2025.
  • Astera Labs was a new CIBC World Markets position in Q4 2025.
  • Astera Labs made up 0.1% of CIBC World Markets's portfolio in Q4 2025, its #139 holding.
  • 701 funds tracked by Wall St. Rank held Astera Labs as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.